alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### UNITED STATES of America, Plaintiff-Appellee, v. Lazaro VILLALBA, Defendant-Appellant.

No. 08-13958

Non-Argument Calendar.

United States Court of Appeals, Eleventh Circuit.

May 8, 2009.

Lazaro Villalba, McRae, GA, pro se.

Anne R. Schultz, U.S. Attorney’s Office, Miami, FL, for Plaintiff-Appellee.

Before TJOFLAT, DUBINA and HILL, Circuit Judges.

PER CURIAM:

Richard F. Della Fera, appointed counsel for Lazaro Villalba in this direct criminal appeal, has moved to withdraw from *873further representation and filed a brief pursuant to *Anders v. California,*386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967). Our independent review of the entire record confirms that there are no issues of arguable merit on appeal. Therefore, counsel’s motion to withdraw is GRANTED, and Villalba’s conviction and sentence are AFFIRMED. The motion for appointment of alternate counsel is DENIED.
No. 775.

#### Wilmington Trust Co., Executor, *v.*Helvering, Commissioner of Internal Revenue.

January 12, 1942.

*Mr. Wm. 8. Potter*for petitioner.' *Solicitor General Fahy, Assistant Attorney General Clark,*and *Messrs. J. Louis Monarch*and *Morton K. Rothschild*for respondent.

Petition for writ of certiorari to the Circuit Court of Appeals for the Third Circuit granted, limited to the question whether the Circuit Court of Appeals should have set aside the findings of the Board of Tax Appeals relating to question 1 (a) of the petition for writ of certiorari.
<PAGE>



                                                                    Exhibit 99.4


                         SECTION 906 CERTIFICATION--CEO

In connection with Amendment No. 1 to the Annual Report of Plains Exploration &
Production Company (the "Company") on Form 10-K/A for the period ending December
31, 2002 as filed with the Securities and Exchange Commission on the date hereof
(the "Report"), I, James C. Flores, Chief Executive Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

To the best of my knowledge, after reasonable investigation:

     (1)  The Report fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and


     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.


Dated: April 30, 2003.                  /s/ James C. Flores
                                        ---------------------------------------
                                        James C. Flores
                                        Chief Executive Officer

The foregoing certification is being furnished solely pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002 and is not being filed as part of the Report or
as a separate disclosure document.

A signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
niams.nih.gov

Subscribe to Our E-Newsletters:

niams.nih.gov/newsletters

Online Resources

Health Resources on Bones, Joints,

Muscles, and Skin

National Institute of Arthritis and Musculoskeletal and Skin Diseases

News and 

Updates

y NIAMS research

news, images,

and videos

Resources for Community Outreach

y Social media tools, e-newsletters, and free

resources for outreach efforts

Clinical Trials

y Information

for patients on

participating in

clinical trials

For more information:

niams.nih.gov

National Institutes of Health

877–22–NIAMS|301–565–2966 (TTY) NIH... Turning Discovery Into Health®

Connect with us!

“What Is NIAMS?”

y NIAMS organizational

overview

Health Information

y Indexed A to Z or search by category

y Mobile-friendly health information

y Basics and In-Depth versions

y All topics are available in Spanish,

and select topics are available in

Chinese, Korean, and Vietnamese.

Multilingual Resources

y Health information in Chinese,

Korean, and Vietnamese

y Spanish-language portal

niams.nih.gov/about/what-is-niams

niams.nih.gov/community-outreach-initiative

niams.nih.gov/clinical-trials

niams.nih.gov/health-topics

niams.nih.gov/community-outreach-initiative/

resources-other-languages

niams.nih.gov/

newsroom

Follow Us on Social Media:

twitter.com/NIH_NIAMS facebook.com/NIH.NIAMS youtube.com/NIAMS
II 

111TH CONGRESS 

1ST SESSION S. 2503 

To suspend temporarily the duty on nPBAL. 

IN THE SENATE OF THE UNITED STATES 

OCTOBER 29, 2009 

Mr. GRAHAM introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To suspend temporarily the duty on nPBAL. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. nPBAL. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.01.00 4-Propylbenzaldehyde (CAS 

No. 28785–06–0) (provided 

for in subheading 

2912.29.60) ........................... Free No change No change On or before 

12/31/2011 ’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 subsection (a) applies to articles entered, or withdrawn 


jbell on DSKDVH8Z91PROD with BILLS
2 

•S 2503 IS

1 from warehouse for consumption, on or after the 15th day 

2 after the date of the enactment of this Act. 

Æ 


jbell on DSKDVH8Z91PROD with BILLS
<!DOCTYPE html>
<html>
<head>
    <meta name="viewport" content="width=device-width" />
    <meta name="robots" content="noindex">
    <title>Hematuria (Blood in the Urine) - NIDDK</title>
    
<meta name="VIcurrentDateTime" content="638490787121661752" />
<meta name="VirtualFolder" content="/" />
<script type="text/javascript" src="/layouts/system/VisitorIdentification.js"></script>

</head>
<body>
    <div></div>
</body>
</html>
[Federal Register Volume 74, Number 14 (Friday, January 23, 2009)]
[Notices]
[Page 4309]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-1271]


-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

Internal Revenue Service


Open Meeting of the Taxpayer Assistance Center Committee of the 
Taxpayer Advocacy Panel

AGENCY: Internal Revenue Service (IRS), Treasury.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: An open meeting of the Taxpayer Assistance Center Committee of 
the Taxpayer Advocacy Panel will be conducted. The Taxpayer Advocacy 
Panel (TAP) is soliciting public comments, ideas, and suggestions on 
improving customer service at the Internal Revenue Service.

DATES: The meeting will be held Tuesday, March 24, 2009.

FOR FURTHER INFORMATION CONTACT: Ellen Smiley at 1-888-912-1227 or 414-
231-2360.

SUPPLEMENTARY INFORMATION: Notice is hereby given pursuant to Section 
10(a)(2) of the Federal Advisory Committee Act, 5 U.S.C. App. (1988) 
that an open meeting of the Taxpayer Assistance Center Committee of the 
Taxpayer Advocacy Panel will be held Tuesday, March 24, 2009, at 1 p.m. 
Central Time. For more information, please contact Ellen Smiley. Ms. 
Smiley can be reached at 1-888-912-1227 or 414-231-2360. If you would 
like to have the TAP consider a written statement, write to Ellen 
Smiley at 211 West Wisconsin Avenue, Milwaukee, WI 53203-2221, or you 
can contact us at http://www.improveirs.org.
    The agenda will include the following: Various IRS issues.

    Dated: January 13, 2009.
Shawn F. Collins,
Acting Director, Taxpayer Advocacy Panel.
 [FR Doc. E9-1271 Filed 1-22-09; 8:45 am]
BILLING CODE 4830-01-P
II 

111TH CONGRESS 

1ST SESSION S. 2626 

To extend the temporary suspension of duty on polytetramethylene ether 

glycol. 

IN THE SENATE OF THE UNITED STATES 

NOVEMBER 2, 2009 

Mr. SCHUMER introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on 

polytetramethylene ether glycol. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. POLYTETRAMETHYLENE ETHER GLYCOL. 

4 (a) IN GENERAL.—Heading 9902.02.98 of the Har5 monized Tariff Schedule of the United States (relating to 

6 polytetramethylene ether glycol) is amended by striking 

7 ‘‘12/31/2009’’ and inserting ‘‘12/31/2011’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 subsection (a) applies to goods entered, or withdrawn from 


pwalker on DSK8KYBLC1PROD with BILLS
2 

•S 2626 IS

1 warehouse for consumption, on or after the 15th day after 

2 the date of the enactment of this Act. 

Æ 


pwalker on DSK8KYBLC1PROD with BILLS
```

[Federal Register Volume 74, Number 201 (Tuesday, October 20, 2009)]
[Notices]
[Page 53742]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-25164]

-----------------------------------------------------------------------

FEDERAL COMMUNICATIONS COMMISSION

[Report No. 2900]

Petition for Reconsideration of Action in Rulemaking Proceeding

Oct 15, 2009.
SUMMARY: A Petition for Reconsideration has been filed in the 
Commission's Rulemaking proceeding listed in this Public Notice and 
published pursuant to 47 CFR Section 1.429(e). The full text of this 
document is available for viewing and copying in Room CY-B402, 445 12th 
Street, SW, Washington, DC or may be purchased from the Commission's 
copy contractor, Best Copy and Printing, Inc. (BCPI) (1-800-378-3160). 
Oppositions to this petition must be filed by November 4, 2009. See 
Section 1.4(b)(1) of the Commission's rules (47 CFR 1.4(b)(1)). Replies 
to an opposition must be filed within 10 days after the time for filing 
oppositions has expired.
    Subject: In the Matter of Amendment of Parts 73 and 74 of the 
Commission's Rules to Establish Rules for Replacement Digital Low Power 
Television Translator Stations (MB Docket No. 08-253)
    NUMBER OF PETITIONS FILED: 1

Federal Communications Commission
Marlene H. Dortch,
Secretary.
[FR Doc. E9-25164 Filed 10-19-09; 8:45 am]
BILLING CODE 6712-01-S
```
Exhibit 32

CERTIFICATIONS

The
undersigned certify pursuant to 18 U.S.C. Section 1350, that:

| |     |                                                                                                                                                                                                                        
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | (1) | The
  accompanying Rimage Corporation Annual Report on Form 10-K for the period
  ended December 31, 2007, fully complies with the requirements of Section 13(a)
  or 15(d) of the Securities Exchange Act of 1934; and
| |     |                                                                                                                                                                                                                        
| | (2) | The
  information contained in the accompanying report fairly presents, in all
  material respects, the financial condition and results of operations of the
  Company.                                                

|                 |  |                          
|---------------- |  | -------------------------
|March 14,
  2008 |  | /s/  Bernard
  P. Aldrich
|                 |  | Chief
  Executive Officer
|                 |  |                          
|                 |  | /s/  Robert
  M. Wolf    
|                 |  | Chief
  Financial Officer

59

---
**EXHIBIT 32.1**

 

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

**(pursuant to Section 906 of the Sarbanes-OxleyAct of 2002 (18 U.S.C.§1350))**

 

Pursuant toSection 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. §1350), theundersigned, Leonard P. Shaykin, Chairman of the Board of Directors and ChiefExecutive Officer of Tapestry Pharmaceuticals, Inc. (the “Company”) doeshereby certify, to his knowledge, that:

 

(a)                                  theAnnual Report on Form 10-K for the fiscal year ended December 29, 2004 ofthe Company (the “Report”) fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of 1934,and

 

(b)                                 theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

 

Date: February 23, 2005

 
|       | /s/ LEONARD P. SHAYKIN                 |       |
|------------|----------------------------------------|------------|
|       | **Leonard P. Shaykin**                 |       |
|       | **Chairman of the Board of Directors** |       |
|       | **and**                                |       |
| ** ** | **Chief Executive Officer**            | ** ** |

 

A signed original of thiswritten statement required by Section 906 has been provided to TapestryPharmaceuticals, Inc. and will be retained by TapestryPharmaceuticals, Inc. and furnished to the Securities and ExchangeCommission or its staff upon request.  Thiscertification “accompanies” the Form 10-K to which it relates, is not deemedfiled with the SEC and is not to be incorporated by reference into any filingof the Company under the Securities Act of 1933, as amended, or the SecuritiesExchange Act of 1934, as amended (whether made before or after the date of theForm 10-K), irrespective of any general incorporation language contained insuch filing.

 

----
**UN PUBLISHED** 

UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 15**  **- 6**  **345**

UNITED STATES OF AMERICA , Plaintiff

- Appellee ,

v. LEONARD ANDRE HUDSON, a/k/a Steven Orlando Hudson, a/k/a Dantee Keys , Defendant

- Appellant

.

Appeal from the United States District Court for the Western District of Virginia , at Abingdon

. James P. Jones , District Judge. ( 1 : 07

- cr - 00 016

- JPJ

- 1 )

Submitted : May 21, 2015 Decided: May 27, 2015

Before MOTZ , KING, and WYNN , Circuit Judges.

Affirm ed by un published per curiam opinion

.

Leonard Andre Hudson , Appellant Pro Se. Jennifer R. Bockhorst , Assistant U nited S tates Attorney , Abingdon, Virginia , for Appellee

.
Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM : Leonard Andre Hudson appeals the district court’s order denying his 18 U.S.C. § 3582(c)(2) (2012) motion for a sentence
reduction. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the
district court. United States v. Hudson , No. 1:07

- cr - 00016

- JPJ

1 (W.D. Va. Feb. 25, 2015). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this court and argument would not aid the decisional process.

AFFIRMED
#### Patrick Percy JOHNSON, Jr., Petitioner-Appellant, v. UNITED STATES of America, Respondent-Appellee.

No. 06-6865.

United States Court of Appeals, Fourth Circuit.

Submitted: Oct. 31, 2006.

Decided: Nov. 3, 2006.

Patrick Percy Johnson, Jr., Appellant Pro Se.

Before WILLIAMS, MICHAEL, and GREGORY, Circuit Judges.

Dismissed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).

PER CURIAM:

Patrick Percy Johnson, Jr., seeks to appeal the district court’s order denying relief on his 28 U.S.C. § 2255 (2000) motion. The order is not appealable unless a circuit justice or judge issues a certificate of appealability. 28 U.S.C. § 2253(c)(1) (2000). A certificate of appealability will not issue absent “a substantial showing of the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) (2000). A prisoner satisfies this standard by demonstrating that reasonable jurists would find that any assessment of the constitutional claims by the district court is debatable or wrong and that any dispositive procedural ruling by the district court is likewise debatable. *Miller-El v. Cockrell,*537 U.S. 322, 336-38, 123 S.Ct. 1029, 154 L.Ed.2d 931 (2003); *Slack v. McDaniel,*529 U.S. 473, 484, 120 S.Ct. 1595, 146 L.Ed.2d 542 (2000); *Rose v. Lee,*252 F.3d 676, 683-84 (4th Cir.2001). We have independently reviewed the record and conclude that Johnson has not made the requisite showing. Accordingly, we deny a certificate of appealability and dismiss the appeal. Because the district court has denied Johnson’s motion for reconsideration, we deny as moot Johnson’s motion for stay and remand. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*DISMISSED.*
Exhibit 23.1


Independent Auditors' Consent


Board of Directors
DATA RACE, Inc.:

We consent to incorporation by reference in the Registration Statements (No.
33-75800, No. 333-24303, No. 333-24305, No. 333-38450, No. 333-57058, No.
333-63590, No. 333-72505 and No. 333-77713) on Form S-8 and in the Registration
Statements (No. 333-22605, No. 333-57166, No. 333-41286, No. 333-42203, No.
333-53757, No. 333-62147, No. 333-71319 and No. 333-83595), No. 333-94601 on
Form S-3 of DATA RACE, Inc. of our report dated September 11, 2000, relating to
the balance sheets of DATA RACE, Inc. as of June 30, 2000 and the related
statements of operations, shareholders' equity and cash flows for each of the
years in the two-year period ended June 30, 2000, which report appears in the
June 30, 2001 annual report on Form 10-K of DATA RACE, Inc.


                                                   KPMG LLP

San Antonio, Texas
December 5, 2001
#### In the Matter of Caleb G. and Others, Infants. Steuben County Department of Social Services, Respondent; Doniele (G.)T., Appellant, et al., Respondent.

(Appeal No. 1.)

[964 NYS2d 55]

Appeal from an order of the Family Court, Steuben County (Marianne Furfure, A.J.), entered August 24, 2011 in a proceeding pursuant to Family Court Act article 10. The order, among other things, adjudged that Caleb G., Erika G. and Kristen L. were neglected by respondents.

It is hereby ordered that the order so appealed from is unanimously affirmed without costs.

Present—Smith, J.P., Peradotto, Lindley, Valentino and Whalen, JJ.
<!DOCTYPE html>
<html>
<head>
    <meta name="viewport" content="width=device-width" />
    <meta name="robots" content="noindex">
    <title>Visit Us - NIDDK</title>
    
<meta name="VIcurrentDateTime" content="638490780531965796" />
<meta name="VirtualFolder" content="/" />
<script type="text/javascript" src="/layouts/system/VisitorIdentification.js"></script>

</head>
<body>
    <div></div>
</body>
</html>
II 

111TH CONGRESS 

1ST SESSION S. 2625 

To extend the temporary suspension of duty on magnesium aluminum hydroxide carbonate (synthetic hydrotalcite) and magnesium aluminum hydroxide carbonate (synthetic hydrotalcite) coated with stearic acid. 

IN THE SENATE OF THE UNITED STATES 

NOVEMBER 2, 2009 

Mr. SCHUMER introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on magnesium 

aluminum hydroxide carbonate (synthetic hydrotalcite) 

and magnesium aluminum hydroxide carbonate (synthetic 

hydrotalcite) coated with stearic acid. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


tjames on DSKG8SOYB1PROD with BILLS
2 

•S 2625 IS

1 SECTION 1. MAGNESIUM ALUMINUM HYDROXIDE CAR2 BONATE (SYNTHETIC HYDROTALCITE) AND 

3 MAGNESIUM ALUMINUM HYDROXIDE CAR4 BONATE (SYNTHETIC HYDROTALCITE) COAT5 ED WITH STEARIC ACID. 

6 (a) IN GENERAL.—Heading 9902.05.32 of the Har7 monized Tariff Schedule of the United States (relating to 

8 magnesium aluminum hydroxide carbonate (synthetic 

9 hydrotalcite) and magnesium aluminum hydroxide car10 bonate (synthetic hydrotalcite) coated with stearic acid) 

11 is amended— 

12 (1) by amending the article description to read 

13 as follows: ‘‘Magnesium aluminum hydroxide car14 bonate (synthetic hydrotalcite) (CAS No. 11097–59– 

15 9) (provided for in subheading 2842.90.90); and 

16 magnesium aluminum hydroxide carbonate (syn17 thetic hydrotalcite) (CAS No. 11097–59–9) coated 

18 with stearic acid (CAS No. 57–11–4) (provided for 

19 in subheading 3812.30.90)’’; and 

20 (2) in the effective period column, by striking 

21 ‘‘12/31/2009’’ and inserting ‘‘12/31/2011’’. 

22 (b) EFFECTIVE DATE.—The amendment made by 

23 subsection (a) applies to goods entered, or withdrawn from 

24 warehouse for consumption, on or after the 15th day after 

25 the date of the enactment of this Act. 

Æ 


tjames on DSKG8SOYB1PROD with BILLS
<TABLE> <S> <C>

<ARTICLE>          5
<MULTIPLIER>       1

<S>                                                <C>
<PERIOD-TYPE>                                       3-MOS
<FISCAL-YEAR-END>                                   DEC-31-2001
<PERIOD-END>                                        MAR-31-2001
<CASH>                                                         21,169
<SECURITIES>                                                        0
<RECEIVABLES>                                                   2,500
<ALLOWANCES>                                                        0
<INVENTORY>                                                         0
<CURRENT-ASSETS>                                               23,669
<PP&E>                                                              0
<DEPRECIATION>                                                      0
<TOTAL-ASSETS>                                                 23,669
<CURRENT-LIABILITIES>                                          83,000
<BONDS>                                                             0
<PREFERRED-MANDATORY>                                               0
<PREFERRED>                                                         0
<COMMON>                                                   52,044,501
<OTHER-SE>                                                          0
<TOTAL-LIABILITY-AND-EQUITY>                                   23,669
<SALES>                                                             0
<TOTAL-REVENUES>                                                2,576
<CGS>                                                               0
<TOTAL-COSTS>                                                   8,850
<OTHER-EXPENSES>                                                    0
<LOSS-PROVISION>                                                    0
<INTEREST-EXPENSE>                                                  0
<INCOME-PRETAX>                                                (6,274)
<INCOME-TAX>                                                        0
<INCOME-CONTINUING>                                            (6,274)
<DISCONTINUED>                                                      0
<EXTRAORDINARY>                                                     0
<CHANGES>                                                           0
<NET-INCOME>                                                   (6,274)
<EPS-BASIC>                                                       0
<EPS-DILUTED>                                                       0




</TABLE>